SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-257247
Filing Date
2017-08-14
Accepted
2017-08-14 16:10:29
Documents
52
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d423255d10q.htm 10-Q 333856
2 EX-31.1 d423255dex311.htm EX-31.1 5938
3 EX-31.2 d423255dex312.htm EX-31.2 5921
4 EX-32.1 d423255dex321.htm EX-32.1 2627
5 EX-32.2 d423255dex322.htm EX-32.2 2600
  Complete submission text file 0001193125-17-257247.txt   2484411

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ogen-20170630.xml EX-101.INS 303922
7 XBRL TAXONOMY EXTENSION SCHEMA ogen-20170630.xsd EX-101.SCH 38369
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ogen-20170630_cal.xml EX-101.CAL 39103
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ogen-20170630_def.xml EX-101.DEF 147585
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogen-20170630_lab.xml EX-101.LAB 306177
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogen-20170630_pre.xml EX-101.PRE 227532
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 171030237
SIC: 2834 Pharmaceutical Preparations